Company
Aura Biosciences, Inc. (AURA)
Standardized SEC financial data for Aura Biosciences, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001501796 · NASDAQ · Biological Products, (No Diagnostic Substances).
Return on equity
-77.6%
Free cash flow
-$85.2M
Current ratio
8.15×
EPS (diluted)
$-1.76
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| R&D expense | $18.0M | $25.2M | $42.2M | $65.2M | $73.3M | $90.3M |
| SG&A expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $17.5M | $149.2M | $188.8M | $41.9M | $32.5M | $144.2M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$24.3M | -$32.4M | -$54.6M | -$63.8M | -$79.8M | -$84.7M |
| Capital expenditures |
Get AURA data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/AURA/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/AURA/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"